Ideaya Biosciences Inc. buy nvestor
Start price
08.01.22
/
50%
€15.30
Target price
08.01.23
€30.00
Performance (%)
-14.38%
End price
22.01.22
€13.10
Summary
This prediction ended on 22.01.22 with a price of €13.10. The prediction for Ideaya Biosciences Inc. disappointed with a performance of -14.38%. nvestor has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Ideaya Biosciences Inc. | 1.163% | 1.163% | 110.909% |
iShares Core DAX® | 2.594% | -1.158% | 14.782% |
iShares Nasdaq 100 | 3.553% | -1.727% | 43.265% |
iShares Nikkei 225® | 0.687% | -8.354% | 18.454% |
iShares S&P 500 | 2.209% | -0.942% | 31.361% |
According to nvestor what are the pros and cons of Ideaya Biosciences Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
High dividend yield expected
Fair valuation
Good rating
Standard Investments for future growth
positive Cash Flow expected
Valuable balance sheet
ROE higher than 10% per year
Normal challenges to pay loans and raise capital
Capable Management
Good culture
Innovative
Some uniques
Differentiated customer and product portfolio
Growths faster than the competition
Sustainability is important
Stable Large shareholder and/or long term investor
Medium risks for its business
Top 10 in its market
Small cyclical dependencies
Known brand
Future proof or reliable business model
Cons
Comments by nvestor for this prediction
In the thread Ideaya Biosciences Inc. diskutieren
Buy mit Kursziel 30,0
In the thread Trading Ideaya Biosciences Inc.
Einschätzung wurde nach dem Ende von Catch the Monkey automatisch beendet.